HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+15.65%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$219M
AUM Growth
+$219M
(+78%)
Cap. Flow
+$84.3M
Cap. Flow
% of AUM
38.57%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
163
New
55
Increased
48
Reduced
23
Closed
29
Top Buys
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
$31.6M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$3.49M |
| 3 |
AJRD
Aerojet Rocketdyne Holdings, Inc.
AJRD
|
$3.38M |
| 4 |
TXNM
TXNM Energy, Inc.
TXNM
|
$3.15M |
| 5 |
Indivior
INDV
|
$3.09M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$4.25M |
| 2 |
Coupang
CPNG
|
$4.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$3.46M |
| 4 |
TEGNA Inc
TGNA
|
$2.44M |
| 5 |
First Horizon
FHN
|
$2.41M |
Sector Composition
| 1 | Healthcare | 46.57% |
| 2 | Technology | 13.44% |
| 3 | Communication Services | 5.29% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Fiserv
FI
$74.3B
| $953K | 0.44% |
7,553
+1,871
| +33% | +$236K |
|
52
Lithia Motors
LAD
$8.51B
| $943K | 0.43% |
+3,101
| New | +$943K |
|
|
ALPN
53
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $928K | 0.42% |
90,287
| – | – |
|
54
PennyMac Financial
PFSI
$5.83B
| $924K | 0.42% |
+13,137
| New | +$924K |
|
55
Roper Technologies
ROP
$56.4B
| $920K | 0.42% |
1,913
+1,183
| +162% | +$569K |
|
56
Merus
MRUS
$5.04B
| $896K | 0.41% |
34,027
-11,930
| -26% | -$314K |
|
57
WESCO International
WCC
$10.6B
| $895K | 0.41% |
4,997
+3,137
| +169% | +$562K |
|
58
Aclaris Therapeutics
ACRS
$223M
| $893K | 0.41% |
86,103
-111,700
| -56% | -$1.16M |
|
59
Laureate Education
LAUR
$4.12B
| $858K | 0.39% |
71,007
+45,107
| +174% | +$545K |
|
60
First Citizens BancShares
FCNCA
$25.7B
| $848K | 0.39% |
+661
| New | +$848K |
|
61
Celldex Therapeutics
CLDX
$1.57B
| $839K | 0.38% |
24,742
| – | – |
|
62
Trip.com Group
TCOM
$46.6B
| $831K | 0.38% |
+23,729
| New | +$831K |
|
63
89bio
ETNB
$1.37B
| $827K | 0.38% |
+43,639
| New | +$827K |
|
64
Biomea Fusion
BMEA
$114M
| $825K | 0.38% |
+37,600
| New | +$825K |
|
65
Palo Alto Networks
PANW
$128B
| $819K | 0.37% |
+3,205
| New | +$819K |
|
66
Protagonist Therapeutics
PTGX
$3.62B
| $806K | 0.37% |
+29,179
| New | +$806K |
|
67
Huazhu Hotels Group
HTHT
$11.2B
| $804K | 0.37% |
+20,729
| New | +$804K |
|
68
Baidu
BIDU
$33.1B
| $792K | 0.36% |
+5,786
| New | +$792K |
|
69
Bausch Health
BHC
$2.72B
| $787K | 0.36% |
+98,351
| New | +$787K |
|
70
Amicus Therapeutics
FOLD
$2.42B
| $786K | 0.36% |
62,581
-14,733
| -19% | -$185K |
|
71
Duolingo
DUOL
$12.9B
| $781K | 0.36% |
+5,467
| New | +$781K |
|
72
Alnylam Pharmaceuticals
ALNY
$58.6B
| $770K | 0.35% |
4,056
| – | – |
|
73
AnaptysBio
ANAB
$630M
| $766K | 0.35% |
37,651
+12,432
| +49% | +$253K |
|
74
Frontier Communications
FYBR
$9.28B
| $761K | 0.35% |
40,846
+32,016
| +363% | +$597K |
|
75
RXO
RXO
$2.62B
| $757K | 0.35% |
+33,383
| New | +$757K |
|